Nano-capture technology of CXCL13 could reduce tBreg differentiation and normalize epithelial-mesenchymal transition in the TME, thereby inhibiting tumor growth and prolonging the PFS in pancreatic cancer, BRAF mutant melanoma, and TNBC murine models 191. The gene discussed is CXCL13; the disease is neoplasm.